can semaglutide cause kidney issues Cardio-kidney-metabolic protective effects of across the spectrum of chronic disease FLOW trial Ozempic® (semaglutide injection)

10, 2024 "Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly (CMS-4208-F)" Centers for Medicare & Medicaid Services

This positions semaglutide as more than just a weight loss treatmentit is a tool for improving long-term health outcomes

The 0.25 mg dose is the starter rather than the maintenance target

Key points: GLP-1 receptor agonists (GLP-1s) are a class of medications that mimic the actions of the hormone GLP-1, which helps regulate hunger and blood sugar levels GLP-1s help the pancreas release more insulin, delay stomach emptying, and reduce appetite Wegovy and Trulicity mimic the action of GLP-1 and decrease appetite and blood sugar levels 2 Wegovy vs Trulicity: Which is better for weight loss

Dose-specific weight loss outcomes for tirzepatide Source: SURMOUNT-1 trial (Jastreboff et al., NEJM 2022)